Author:
Kleckner Ian R.,Park Susanna B.,Streckmann Fiona,Wiskemann Joachim,Hardy Sara,Mohile Nimish
Publisher
Springer International Publishing
Reference42 articles.
1. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470. https://doi.org/10.1016/j.pain.2014.09.020
2. Chan A, Hertz DL, Morales M, Adams EJ, Gordon S, Tan CJ et al (2019) Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview. Support Care Cancer:1–9. https://pubmed.ncbi.nlm.nih.gov/31363906/
3. Staff NP, Grisold A, Grisold W, Windebank AJ (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772–781. https://doi.org/10.1002/ana.24951
4. Gu Y, Menzies AM, Long GV, Fernando S, Herkes G (2017) Immune mediated neuropathy following checkpoint immunotherapy. J Clin Neurosci 45:14–17
5. Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A et al (2012) Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: north central Cancer treatment group trial N08C1. Cancer 118(20):5171–5178
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献